Back
Intra-Cellular Therapies Stock Price Chart
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.
Sell
49
ITCI
Intra-Cellular Therapies
Last Price:
71.33
Seasonality Move:
8.06%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.- The current trend is moderately bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.39 | Buy |
| 20-day SMA: | 69.02 | Buy |
| 50-day SMA: | 69.22 | Buy |
| 200-day SMA: | 61.97 | Buy |
| 8-day EMA: | 71.44 | Buy |
| 20-day EMA: | 69.58 | Buy |
| 50-day EMA: | 68.54 | Buy |
| 200-day EMA: | 63.5 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.25 | Buy |
| Relative Strength Index (14 RSI): | 54.62 | Buy |
| Chaikin Money Flow: | -2438488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.89 - 71.73) | Buy |
| Bollinger Bands (100): | (63.85 - 71.61) | Buy |
Intra-Cellular Therapies Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 72.04 while ITCI 8-day simple moving average is 70.39, which is a Buy signal.
- The stock price of ITCI is 72.04 while Intra-Cellular Therapies 20-day SMA is 69.02, which makes it a Buy.
- Intra-Cellular Therapies 50-day simple moving average is 69.22 while ITCI share price is 72.04, making it a Buy technically.
- ITCI stock price is 72.04 and Intra-Cellular Therapies 200-day simple moving average is 61.97, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Sell
49
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Sell
The current Intra-Cellular Therapies [ITCI] share price is $72.04. The Score for ITCI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
6.97B
Price in USD:
72.04
Share Volume:
4.29M
Intra-Cellular Therapies 52-Week Range
52-Week High:
84.89
52-Week Low:
45.50
Sell
49
Intra-Cellular Therapies (ITCI)
is a Sell
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 72.04 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 72.04 while ITCI 8-day exponential moving average is 71.44, which is a Buy signal.
- The stock price of ITCI is 72.04 while Intra-Cellular Therapies 20-day EMA is 69.58, which makes it a Buy.
- Intra-Cellular Therapies 50-day exponential moving average is 68.54 while ITCI share price is 72.04, making it a Buy technically.
- ITCI stock price is 72.04 and Intra-Cellular Therapies 200-day simple moving average is 63.50, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.90 per share, and an increase next year of $1.58 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is 1.25, suggesting Intra-Cellular Therapies is a Buy
- Intra-Cellular Therapies Relative Strength Index (RSI) is 54.62, which suggest Intra-Cellular Therapies is overbought
- The Bollinger Bands (25) for Intra-Cellular Therapies is (64.89 - 71.73), which suggest Intra-Cellular Therapies is a Buy
- The Bollinger Bands (100) for Intra-Cellular Therapies is (63.85 - 71.61), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.